Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: a single-centre, open-label, dose-finding, non-randomised, phase 1b trial-Reference-Cited by-同舟云学术

Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: a single-centre, open-label, dose-finding, non-randomised, phase 1b trial

Published:2016-05 Issue:5 Volume:17 Page:651-662
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Nywening Timothy M,Wang-Gillam Andrea,Sanford Dominic E,Belt Brian A,Panni Roheena Z,Cusworth Brian M,Toriola Adetunji T,Nieman Rebecca K,Worley Lori A,Yano Motoyo,Fowler Kathryn J,Lockhart A Craig,Suresh Rama,Tan Benjamin R,Lim Kian-Huat,Fields Ryan C,Strasberg Steven M,Hawkins William G,DeNardo David G,Goedegebuure S Peter,Linehan David C

Funder

National Institutes of Health (NIH)

NIH

Publisher

Elsevier BV

Subject

Oncology

Reference30 articles.

1. Cancer statistics, 2014;Siegel;CA Cancer J Clin,2014

2. Pancreatic cancer;Vincent;Lancet,2011

3. Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine;Von Hoff;N Engl J Med,2013

4. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer;Conroy;N Engl J Med,2011

5. Dynamics of the immune reaction to pancreatic cancer from inception to invasion;Clark;Cancer Res,2007

Cited by 610 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Macrophage crosstalk and therapies: Between tumor cells and immune cells;International Immunopharmacology;2024-11

2. Updates in Molecular Profiling of Pancreatic Ductal Adenocarcinoma;Surgical Clinics of North America;2024-10

3. Barriers and opportunities in pancreatic cancer immunotherapy;npj Precision Oncology;2024-09-12

4. The Role of Tumor Microenvironment in Pancreatic Cancer Immunotherapy: Current Status and Future Perspectives;International Journal of Molecular Sciences;2024-09-03

5. Unveiling the contribution of tumor-associated macrophages in driving epithelial-mesenchymal transition: a review of mechanisms and therapeutic Strategies;Frontiers in Pharmacology;2024-09-02